BridgeBio Pharma Inc
(NAS:BBIO)
$
29.08
-0.37 (-1.26%)
Market Cap: 5.50 Bil
Enterprise Value: 6.97 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 41/100 
BridgeBio Pharma Inc and Eidos Therapeutics Inc at Leerink Global Healthcare Conference Transcript
Feb 25, 2020 / 06:00PM GMT
Release Date Price:
$31.94
(-3.94%)
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
Good afternoon. I'm -- The floor is back from lunch. I'm Mani Foroohar, Managing Director and senior analyst here at SVB Leerink, covering genetic medicines, and I'm overjoyed to introduce the Neil Kumar.
Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director
That's nice of you.
Mani Foroohar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
Of BridgeBio and Eidos Therapeutics. You -- so you're a CEO of 1/7 of my whole coverage universe right now.
Neil Kumar
BridgeBio Pharma, Inc. - Co-Founder, CEO & Director
I guess that's a good thing.
Mani Foroohar;Neil Kumar
SVB Leerink LLC, Research Division - MD of Genetic Medicines & Senior Research Analyst
Do you want to hop through a couple of slides, talk about like, overview of the story?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers